//	HYPE.documents["cierre"]

(function HYPE_DocumentLoader() {
	var resourcesFolderName = "cierre_Resources";
	var documentName = "cierre";
	var documentLoaderFilename = "cierre_hype_generated_script.js";

	// find the URL for this script's absolute path and set as the resourceFolderName
	try {
		var scripts = document.getElementsByTagName('script');
		for(var i = 0; i < scripts.length; i++) {
			var scriptSrc = scripts[i].src;
			if(scriptSrc != null && scriptSrc.indexOf(documentLoaderFilename) != -1) {
				resourcesFolderName = scriptSrc.substr(0, scriptSrc.lastIndexOf("/"));
				break;
			}
		}
	} catch(err) {	}

	// Legacy support
	if (typeof window.HYPE_DocumentsToLoad == "undefined") {
		window.HYPE_DocumentsToLoad = new Array();
	}
 
	// load HYPE.js if it hasn't been loaded yet
	if(typeof HYPE_100 == "undefined") {
		if(typeof window.HYPE_100_DocumentsToLoad == "undefined") {
			window.HYPE_100_DocumentsToLoad = new Array();
			window.HYPE_100_DocumentsToLoad.push(HYPE_DocumentLoader);

			var headElement = document.getElementsByTagName('head')[0];
			var scriptElement = document.createElement('script');
			scriptElement.type= 'text/javascript';
			scriptElement.src = resourcesFolderName + '/' + 'HYPE.js?hype_version=100';
			headElement.appendChild(scriptElement);
		} else {
			window.HYPE_100_DocumentsToLoad.push(HYPE_DocumentLoader);
		}
		return;
	}
	
	var hypeDoc = new HYPE_100();
	
	var attributeTransformerMapping = {b:"i",c:"i",bC:"i",d:"i",aS:"i",M:"i",e:"f",N:"i",f:"d",aT:"i",O:"i",g:"c",aU:"i",P:"i",Q:"i",aV:"i",R:"c",aW:"f",aI:"i",S:"i",T:"i",l:"d",aX:"i",aJ:"i",m:"c",n:"c",aK:"i",X:"i",aZ:"i",A:"c",Y:"i",aL:"i",B:"c",C:"c",D:"c",t:"i",E:"i",G:"c",bA:"c",a:"i",bB:"i"};

var scenes = [{timelines:{"27_hover":{framesPerSecond:30,animations:[{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"27"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"a",e:359,r:1,s:557,o:"27"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"d",e:178,r:1,s:10,o:"27"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:39,o:"27"},{f:"2",t:0,d:1,i:"b",e:296,r:1,s:293,o:"27"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"27"},{f:"2",t:0,d:1,i:"w",e:"<div><div>2. G\u00f3mez- Brice\u00f1o GA. Clinical experience in dyslipidemic patients treated either with rosuvastatin 10 mg/day or ezetimibe/simvastatin 10/20 mg/day in Mexico city. Value in Health 2007;10(3):A37.<br></div></div><div><br></div><div>7. Fonseca FA, Ruiz A, Cardona-Mu\u00f1oz EG et al. The DISCOVERY PENTA study: a DIrect Statin Comparison of LDL-C Value--an Evaluation of Rosuvastatin therapy compared with atorvastatin. Curr Med Res Opin. 2005 Aug;21(8):1307-15.<br></div>",r:1,s:"<br>",o:"27"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"28"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"a",e:429,r:1,s:627,o:"28"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"d",e:178,r:1,s:10,o:"28"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"c",e:284,r:1,s:39,o:"28"},{f:"2",t:0,d:1,i:"b",e:362,r:1,s:359,o:"28"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"28"},{f:"2",t:0,d:1,i:"w",e:"<div><div>2. G\u00f3mez- Brice\u00f1o GA. Clinical experience in dyslipidemic patients treated either with rosuvastatin 10 mg/day or ezetimibe/simvastatin 10/20 mg/day in Mexico city. Value in Health 2007;10(3):A37.<br></div></div><div><br></div><div>7. Fonseca FA, Ruiz A, Cardona-Mu\u00f1oz EG et al. The DISCOVERY PENTA study: a DIrect Statin Comparison of LDL-C Value--an Evaluation of Rosuvastatin therapy compared with atorvastatin. Curr Med Res Opin. 2005 Aug;21(8):1307-15.<br></div>",r:1,s:"<br>",o:"28"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"29"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"a",e:571,r:1,s:769,o:"29"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"d",e:178,r:1,s:10,o:"29"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"29"},{f:"2",t:0,d:1,i:"b",e:433,r:1,s:430,o:"29"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"29"},{f:"2",t:0,d:1,i:"w",e:"<div><div>2. G\u00f3mez- Brice\u00f1o GA. Clinical experience in dyslipidemic patients treated either with rosuvastatin 10 mg/day or ezetimibe/simvastatin 10/20 mg/day in Mexico city. Value in Health 2007;10(3):A37.<br></div></div><div><br></div><div>7. Fonseca FA, Ruiz A, Cardona-Mu\u00f1oz EG et al. The DISCOVERY PENTA study: a DIrect Statin Comparison of LDL-C Value--an Evaluation of Rosuvastatin therapy compared with atorvastatin. Curr Med Res Opin. 2005 Aug;21(8):1307-15.<br></div>",r:1,s:"<br>",o:"29"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"30"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"a",e:650,r:1,s:848,o:"30"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"d",e:178,r:1,s:10,o:"30"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"30"},{f:"2",t:0,d:1,i:"b",e:480,r:1,s:477,o:"30"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"30"},{f:"2",t:0,d:1,i:"w",e:"<div><div>2. G\u00f3mez- Brice\u00f1o GA. Clinical experience in dyslipidemic patients treated either with rosuvastatin 10 mg/day or ezetimibe/simvastatin 10/20 mg/day in Mexico city. Value in Health 2007;10(3):A37.<br></div></div><div><br></div><div>7. Fonseca FA, Ruiz A, Cardona-Mu\u00f1oz EG et al. The DISCOVERY PENTA study: a DIrect Statin Comparison of LDL-C Value--an Evaluation of Rosuvastatin therapy compared with atorvastatin. Curr Med Res Opin. 2005 Aug;21(8):1307-15.<br></div>",r:1,s:"<br>",o:"30"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"30"}],identifier:"27_hover",name:"27_hover",duration:1},"25_hover":{framesPerSecond:30,animations:[{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"25"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"25"},{f:"2",t:0,d:1,i:"a",e:632,r:1,s:830,o:"25"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"25"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"25"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"25"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"25"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:39,o:"25"},{f:"2",t:0,d:1,i:"b",e:221,r:1,s:218,o:"25"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"25"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"25"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"25"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"25"},{f:"2",t:0,d:1,i:"w",e:"3. Schuster H, Barter PJ, Stender S et al. Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study. Am Heart J. 2004 Apr;147(4):705-13.<div><br></div><div>5. Vytorin (ezetimiba/simvastatina) IPP.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"25"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"25"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"26"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"a",e:571,r:1,s:769,o:"26"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"26"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:39,o:"26"},{f:"2",t:0,d:1,i:"b",e:243,r:1,s:240,o:"26"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"26"},{f:"2",t:0,d:1,i:"w",e:"3. Schuster H, Barter PJ, Stender S et al. Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study. Am Heart J. 2004 Apr;147(4):705-13.<div><br></div><div>5. Vytorin (ezetimiba/simvastatina) IPP.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"26"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"27"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"a",e:359,r:1,s:557,o:"27"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"27"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:39,o:"27"},{f:"2",t:0,d:1,i:"b",e:296,r:1,s:293,o:"27"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"27"},{f:"2",t:0,d:1,i:"w",e:"3. Schuster H, Barter PJ, Stender S et al. Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study. Am Heart J. 2004 Apr;147(4):705-13.<div><br></div><div>5. Vytorin (ezetimiba/simvastatina) IPP.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"27"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"28"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"a",e:429,r:1,s:627,o:"28"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"28"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"c",e:284,r:1,s:39,o:"28"},{f:"2",t:0,d:1,i:"b",e:362,r:1,s:359,o:"28"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"28"},{f:"2",t:0,d:1,i:"w",e:"3. Schuster H, Barter PJ, Stender S et al. Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study. Am Heart J. 2004 Apr;147(4):705-13.<div><br></div><div>5. Vytorin (ezetimiba/simvastatina) IPP.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"28"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"29"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"a",e:571,r:1,s:769,o:"29"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"29"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"29"},{f:"2",t:0,d:1,i:"b",e:433,r:1,s:430,o:"29"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"29"},{f:"2",t:0,d:1,i:"w",e:"3. Schuster H, Barter PJ, Stender S et al. Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study. Am Heart J. 2004 Apr;147(4):705-13.<div><br></div><div>5. Vytorin (ezetimiba/simvastatina) IPP.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"29"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"30"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"a",e:650,r:1,s:848,o:"30"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"30"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"30"},{f:"2",t:0,d:1,i:"b",e:480,r:1,s:477,o:"30"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"30"},{f:"2",t:0,d:1,i:"w",e:"3. Schuster H, Barter PJ, Stender S et al. Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study. Am Heart J. 2004 Apr;147(4):705-13.<div><br></div><div>5. Vytorin (ezetimiba/simvastatina) IPP.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"30"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"30"}],identifier:"25_hover",name:"25_hover",duration:1},"30_hover":{framesPerSecond:30,animations:[{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"30"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"a",e:647,r:1,s:848,o:"30"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"d",e:47,r:1,s:10,o:"30"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"30"},{f:"2",t:0,d:1,i:"b",e:480,r:1,s:477,o:"30"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"30"},{f:"2",t:0,d:1,i:"w",e:"<div><div>14. Brewer HB. Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams. Am J Cardiol. 2003; 92(4B):23K-29K.<br></div></div>",r:1,s:"<br>",o:"30"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"30"}],identifier:"30_hover",name:"30_hover",duration:1},"28_hover":{framesPerSecond:30,animations:[{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"28"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"a",e:429,r:1,s:627,o:"28"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"d",e:198,r:1,s:10,o:"28"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"c",e:284,r:1,s:39,o:"28"},{f:"2",t:0,d:1,i:"b",e:362,r:1,s:359,o:"28"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"28"},{f:"2",t:0,d:1,i:"w",e:"<div><div>4. Crestor (Rosuvastatina) IPP.<br></div></div><div><br></div><div>8. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis. The ASTEROID Trial. JAMA. 2006;295(13):1556-1565.<br></div><div><br></div><div>10. Crouse JR 3rd, Raichlen JS, Riley WA et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial JAMA. 2007 Mar 28;297(12):1344-53.<br></div>",r:1,s:"<br>",o:"28"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"29"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"a",e:571,r:1,s:769,o:"29"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"d",e:198,r:1,s:10,o:"29"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"29"},{f:"2",t:0,d:1,i:"b",e:433,r:1,s:430,o:"29"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"29"},{f:"2",t:0,d:1,i:"w",e:"<div><div>4. Crestor (Rosuvastatina) IPP.<br></div></div><div><br></div><div>8. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis. The ASTEROID Trial. JAMA. 2006;295(13):1556-1565.<br></div><div><br></div><div>10. Crouse JR 3rd, Raichlen JS, Riley WA et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial JAMA. 2007 Mar 28;297(12):1344-53.<br></div>",r:1,s:"<br>",o:"29"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"30"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"a",e:650,r:1,s:848,o:"30"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"d",e:198,r:1,s:10,o:"30"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"30"},{f:"2",t:0,d:1,i:"b",e:480,r:1,s:477,o:"30"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"30"},{f:"2",t:0,d:1,i:"w",e:"<div><div>4. Crestor (Rosuvastatina) IPP.<br></div></div><div><br></div><div>8. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis. The ASTEROID Trial. JAMA. 2006;295(13):1556-1565.<br></div><div><br></div><div>10. Crouse JR 3rd, Raichlen JS, Riley WA et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial JAMA. 2007 Mar 28;297(12):1344-53.<br></div>",r:1,s:"<br>",o:"30"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"30"}],identifier:"28_hover",name:"28_hover",duration:1},"26_hover":{framesPerSecond:30,animations:[{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"26"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"a",e:571,r:1,s:769,o:"26"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"26"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:39,o:"26"},{f:"2",t:0,d:1,i:"b",e:243,r:1,s:240,o:"26"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"26"},{f:"2",t:0,d:1,i:"w",e:"4. Crestor (Rosuvastatina) IPP.<div><br></div><div>6. Jones PH, Davidson MH, Stein EA et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin, simvastatine and pravastatin across doses (STELLAR trial). Am J Cardiol 2003;92(2):152-60.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"26"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"27"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"a",e:359,r:1,s:557,o:"27"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"27"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:39,o:"27"},{f:"2",t:0,d:1,i:"b",e:296,r:1,s:293,o:"27"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"27"},{f:"2",t:0,d:1,i:"w",e:"4. Crestor (Rosuvastatina) IPP.<div><br></div><div>6. Jones PH, Davidson MH, Stein EA et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin, simvastatine and pravastatin across doses (STELLAR trial). Am J Cardiol 2003;92(2):152-60.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"27"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"28"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"a",e:429,r:1,s:627,o:"28"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"28"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"c",e:284,r:1,s:39,o:"28"},{f:"2",t:0,d:1,i:"b",e:362,r:1,s:359,o:"28"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"28"},{f:"2",t:0,d:1,i:"w",e:"4. Crestor (Rosuvastatina) IPP.<div><br></div><div>6. Jones PH, Davidson MH, Stein EA et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin, simvastatine and pravastatin across doses (STELLAR trial). Am J Cardiol 2003;92(2):152-60.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"28"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"29"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"a",e:571,r:1,s:769,o:"29"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"29"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"29"},{f:"2",t:0,d:1,i:"b",e:433,r:1,s:430,o:"29"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"29"},{f:"2",t:0,d:1,i:"w",e:"4. Crestor (Rosuvastatina) IPP.<div><br></div><div>6. Jones PH, Davidson MH, Stein EA et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin, simvastatine and pravastatin across doses (STELLAR trial). Am J Cardiol 2003;92(2):152-60.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"29"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"30"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"a",e:650,r:1,s:848,o:"30"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"d",e:115,r:1,s:10,o:"30"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"30"},{f:"2",t:0,d:1,i:"b",e:480,r:1,s:477,o:"30"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"30"},{f:"2",t:0,d:1,i:"w",e:"4. Crestor (Rosuvastatina) IPP.<div><br></div><div>6. Jones PH, Davidson MH, Stein EA et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin, simvastatine and pravastatin across doses (STELLAR trial). Am J Cardiol 2003;92(2):152-60.<br><div><br></div><div><br></div></div>",r:1,s:"<br>",o:"30"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"30"}],identifier:"26_hover",name:"26_hover",duration:1},"24_hover":{framesPerSecond:30,animations:[{f:"2",t:0,d:1,i:"a",e:580,r:1,s:774,o:"24"},{f:"2",t:0,d:1,i:"b",e:198,r:1,s:196,o:"24"},{f:"2",t:0,d:1,i:"w",e:"1. McKenney JM, Jones PH, Adamczyk MA et al. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Curr Med Res Opin. 2003;19(8):689-698.<div><br><div>2. G\u00f3mez- Brice\u00f1o GA. Clinical experience in dyslipidemic patients treated either with rosuvastatin 10 mg/day or ezetimibe/simvastatin 10/20 mg/day in Mexico city. Value in Health 2007;10(3):A37.<br></div></div>",r:1,s:"<br>",o:"24"},{f:"2",t:0,d:1,i:"c",e:264,r:1,s:39,o:"24"},{f:"2",t:0,d:1,i:"d",e:178,r:1,s:10,o:"24"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"24"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"24"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"24"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"24"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"24"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"24"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"24"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"24"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"24"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"24"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"25"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"25"},{f:"2",t:0,d:1,i:"a",e:709,r:1,s:830,o:"25"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"25"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"25"},{f:"2",t:0,d:1,i:"d",e:120,r:1,s:10,o:"25"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"25"},{f:"2",t:0,d:1,i:"c",e:192,r:1,s:39,o:"25"},{f:"2",t:0,d:1,i:"b",e:221,r:1,s:218,o:"25"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"25"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"25"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"25"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"25"},{f:"2",t:0,d:1,i:"w",e:"1. McKenney JM, Jones PH, Adamczyk MA et al. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Curr Med Res Opin. 2003;19(8):689-698.",r:1,s:"<br>",o:"25"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"25"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"26"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"a",e:648,r:1,s:769,o:"26"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"d",e:120,r:1,s:10,o:"26"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"c",e:192,r:1,s:39,o:"26"},{f:"2",t:0,d:1,i:"b",e:243,r:1,s:240,o:"26"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"26"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"26"},{f:"2",t:0,d:1,i:"w",e:"1. McKenney JM, Jones PH, Adamczyk MA et al. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Curr Med Res Opin. 2003;19(8):689-698.",r:1,s:"<br>",o:"26"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"26"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"27"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"a",e:436,r:1,s:557,o:"27"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"d",e:120,r:1,s:10,o:"27"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"c",e:192,r:1,s:39,o:"27"},{f:"2",t:0,d:1,i:"b",e:296,r:1,s:293,o:"27"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"27"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"27"},{f:"2",t:0,d:1,i:"w",e:"1. McKenney JM, Jones PH, Adamczyk MA et al. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Curr Med Res Opin. 2003;19(8):689-698.",r:1,s:"<br>",o:"27"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"27"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"28"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"a",e:506,r:1,s:627,o:"28"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"d",e:120,r:1,s:10,o:"28"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"c",e:207,r:1,s:39,o:"28"},{f:"2",t:0,d:1,i:"b",e:362,r:1,s:359,o:"28"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"28"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"28"},{f:"2",t:0,d:1,i:"w",e:"1. McKenney JM, Jones PH, Adamczyk MA et al. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Curr Med Res Opin. 2003;19(8):689-698.",r:1,s:"<br>",o:"28"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"28"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"29"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"a",e:648,r:1,s:769,o:"29"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"d",e:120,r:1,s:10,o:"29"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"c",e:192,r:1,s:24,o:"29"},{f:"2",t:0,d:1,i:"b",e:433,r:1,s:430,o:"29"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"29"},{f:"2",t:0,d:1,i:"w",e:"1. McKenney JM, Jones PH, Adamczyk MA et al. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Curr Med Res Opin. 2003;19(8):689-698.",r:1,s:"<br>",o:"29"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"30"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"a",e:727,r:1,s:848,o:"30"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"d",e:120,r:1,s:10,o:"30"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"c",e:192,r:1,s:24,o:"30"},{f:"2",t:0,d:1,i:"b",e:480,r:1,s:477,o:"30"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"30"},{f:"2",t:0,d:1,i:"w",e:"1. McKenney JM, Jones PH, Adamczyk MA et al. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Curr Med Res Opin. 2003;19(8):689-698.",r:1,s:"<br>",o:"30"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"30"}],identifier:"24_hover",name:"24_hover",duration:1},kTimelineDefaultIdentifier:{framesPerSecond:30,animations:[{f:"2",t:0,d:0.5,i:"e",e:"1.000000",r:1,s:"0.000000",o:"4"},{f:"2",t:0.5,d:0.5,i:"f",e:"0deg",r:1,s:"177deg",o:"5"},{f:"2",t:0.5,d:0.5,i:"e",e:"1.000000",r:1,s:"0.000000",o:"5"},{f:"2",t:1,d:0.4333334,i:"e",e:"1.000000",r:1,s:"0.000000",o:"15"},{f:"2",t:1,d:0.4333334,i:"f",e:"0deg",r:1,s:"-90deg",o:"15"},{f:"2",t:1.4333334,d:0.36666656,i:"e",e:"1.000000",r:1,s:"0.000000",o:"16"},{f:"2",t:1.4333334,d:0.36666656,i:"f",e:"0deg",r:1,s:"90deg",o:"16"},{f:"2",t:1.8,d:0.36666679,i:"e",e:"1.000000",r:1,s:"0.000000",o:"23"},{f:"2",t:1.8,d:0.36666679,i:"f",e:"0deg",r:1,s:"180deg",o:"23"},{f:"2",t:2.1666667,d:0.099999905,i:"f",e:"-20deg",s:"0deg",o:"23"},{f:"2",t:2.2666667,d:0.33333325,i:"f",e:"0deg",s:"-20deg",o:"23"}],identifier:"kTimelineDefaultIdentifier",name:"Main Timeline",duration:2.5999999},"29_hover":{framesPerSecond:30,animations:[{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"29"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"a",e:571,r:1,s:769,o:"29"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"d",e:60,r:1,s:10,o:"29"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"29"},{f:"2",t:0,d:1,i:"b",e:433,r:1,s:430,o:"29"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"29"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"29"},{f:"2",t:0,d:1,i:"w",e:"<div><div>11. Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med 2008.<br></div></div>",r:1,s:"<br>",o:"29"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"29"},{f:"2",t:0,d:1,i:"g",e:"#FFFFFF",r:1,s:"",o:"30"},{f:"2",t:0,d:1,i:"P",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"a",e:650,r:1,s:848,o:"30"},{f:"2",t:0,d:1,i:"O",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"N",e:2,r:1,s:0,o:"30"},{f:"2",t:0,d:1,i:"d",e:60,r:1,s:10,o:"30"},{f:"2",t:0,d:1,i:"D",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"c",e:269,r:1,s:24,o:"30"},{f:"2",t:0,d:1,i:"b",e:480,r:1,s:477,o:"30"},{f:"2",t:0,d:1,i:"C",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"A",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"B",e:"#FC9229",r:1,s:"#A0A0A0",o:"30"},{f:"2",t:0,d:1,i:"F",e:"left",r:1,s:"center",o:"30"},{f:"2",t:0,d:1,i:"w",e:"<div><div>11. Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med 2008.<br></div></div>",r:1,s:"<br>",o:"30"},{f:"2",t:0,d:1,i:"M",e:2,r:1,s:0,o:"30"}],identifier:"29_hover",name:"29_hover",duration:1}},sceneIndex:0,perspective:"600px",oid:"1",initialValues:{"15":{o:"content-box",h:"p-shot.png",p:"no-repeat",x:"visible",a:34,q:"100% 100%",b:151,j:"absolute",r:"inline",c:381,k:"div",z:"3",d:219,aY:"1",e:"0.000000",f:"-90deg"},"26":{b:240,z:"12",K:"Solid",c:24,L:"Solid",d:10,aS:6,M:0,bD:"none",N:0,aT:6,O:0,g:"",aU:6,P:0,aV:6,j:"absolute",k:"div",A:"#A0A0A0",B:"#A0A0A0",Z:"break-word",r:"inline",C:"#A0A0A0",aM:"26_hover",D:"#A0A0A0",t:13,F:"center",G:"#000000",aP:"pointer",w:"<br>",x:"visible",I:"Solid",a:769,y:"preserve",J:"Solid"},"16":{o:"content-box",w:"",h:"grafica-1.png",p:"no-repeat",x:"visible",a:423,q:"100% 100%",b:115,j:"absolute",r:"inline",c:573,k:"div",z:"4",d:418,aY:"1",e:"0.000000",f:"90deg"},"4":{o:"content-box",h:"fondo.jpg",p:"no-repeat",x:"visible",a:0,q:"100% 100%",b:0,j:"absolute",r:"inline",c:1024,k:"div",z:"1",d:668,e:"0.000000"},"27":{b:293,z:"13",K:"Solid",c:24,L:"Solid",d:10,aS:6,M:0,bD:"none",N:0,aT:6,O:0,g:"",aU:6,P:0,aV:6,j:"absolute",k:"div",A:"#A0A0A0",B:"#A0A0A0",Z:"break-word",r:"inline",C:"#A0A0A0",aM:"27_hover",D:"#A0A0A0",t:13,F:"center",G:"#000000",aP:"pointer",w:"<br>",x:"visible",I:"Solid",a:557,y:"preserve",J:"Solid"},"5":{o:"content-box",h:"logo_gde.png",x:"visible",a:3,q:"100% 100%",b:-1,j:"absolute",r:"inline",c:504,k:"div",z:"2",d:131,aY:"2",e:"0.000000",f:"177deg"},"23":{o:"content-box",h:"slogan.png",p:"no-repeat",x:"visible",a:507,q:"100% 100%",b:550,j:"absolute",r:"inline",c:360,k:"div",z:"9",d:70,aY:"2",e:"0.000000",f:"180deg"},"28":{b:359,z:"14",K:"Solid",c:39,L:"Solid",d:10,aS:6,M:0,bD:"none",N:0,aT:6,O:0,g:"",aU:6,P:0,aV:6,j:"absolute",k:"div",A:"#A0A0A0",B:"#A0A0A0",Z:"break-word",r:"inline",C:"#A0A0A0",aM:"28_hover",D:"#A0A0A0",t:13,F:"center",G:"#000000",aP:"pointer",w:"<br>",x:"visible",I:"Solid",a:627,y:"preserve",J:"Solid"},"24":{b:196,z:"10",K:"Solid",c:24,L:"Solid",d:10,aS:6,M:0,bD:"none",N:0,aT:6,O:0,g:"",aU:6,P:0,aV:6,j:"absolute",k:"div",A:"#A0A0A0",B:"#A0A0A0",Z:"break-word",r:"inline",C:"#A0A0A0",aM:"24_hover",D:"#A0A0A0",t:13,F:"center",G:"#000000",aP:"pointer",w:"<br>",x:"visible",I:"Solid",a:774,y:"preserve",J:"Solid"},"30":{b:477,z:"16",K:"Solid",c:24,L:"Solid",d:10,aS:6,M:0,bD:"none",N:0,aT:6,O:0,g:"",aU:6,P:0,aV:6,j:"absolute",k:"div",A:"#A0A0A0",B:"#A0A0A0",Z:"break-word",r:"inline",C:"#A0A0A0",aM:"30_hover",D:"#A0A0A0",t:13,F:"center",G:"#000000",aP:"pointer",w:"<br>",x:"visible",I:"Solid",a:848,y:"preserve",J:"Solid"},"29":{b:430,z:"15",K:"Solid",c:24,L:"Solid",d:10,aS:6,M:0,bD:"none",N:0,aT:6,O:0,g:"",aU:6,P:0,aV:6,j:"absolute",k:"div",A:"#A0A0A0",B:"#A0A0A0",Z:"break-word",r:"inline",C:"#A0A0A0",aM:"29_hover",D:"#A0A0A0",t:13,F:"center",G:"#000000",aP:"pointer",w:"<br>",x:"visible",I:"Solid",a:769,y:"preserve",J:"Solid"},"25":{b:218,z:"11",K:"Solid",c:24,L:"Solid",d:10,aS:6,M:0,bD:"none",N:0,aT:6,O:0,g:"",aU:6,P:0,aV:6,j:"absolute",k:"div",A:"#A0A0A0",B:"#A0A0A0",Z:"break-word",r:"inline",C:"#A0A0A0",aM:"25_hover",D:"#A0A0A0",t:13,F:"center",G:"#000000",aP:"pointer",w:"<br>",x:"visible",I:"Solid",a:830,y:"preserve",J:"Solid"}},backgroundColor:"#FFFFFF",name:"Untitled Scene"}];


	
	var javascripts = [];


	
	var Custom = {};
	var javascriptMapping = {};
	for(var i = 0; i < javascripts.length; i++) {
		try {
			javascriptMapping[javascripts[i].identifier] = javascripts[i].name;
			eval("Custom." + javascripts[i].name + " = " + javascripts[i].source);
		} catch (e) {
			hypeDoc.log(e);
			Custom[javascripts[i].name] = (function () {});
		}
	}
	
	hypeDoc.setAttributeTransformerMapping(attributeTransformerMapping);
	hypeDoc.setScenes(scenes);
	hypeDoc.setJavascriptMapping(javascriptMapping);
	hypeDoc.Custom = Custom;
	hypeDoc.setCurrentSceneIndex(0);
	hypeDoc.setMainContentContainerID("cierre_hype_container");
	hypeDoc.setResourcesFolderName(resourcesFolderName);
	hypeDoc.setShowHypeBuiltWatermark(0);
	hypeDoc.setShowLoadingPage(false);
	hypeDoc.setDrawSceneBackgrounds(true);
	hypeDoc.setDocumentName(documentName);

	HYPE.documents[documentName] = hypeDoc.API;

	hypeDoc.documentLoad(this.body);
}());

